Elanco Animal Well being (NYSE:ELAN) Given New $20.00 Worth Goal at JPMorgan Chase & Co.

Elanco Animal Well being (NYSE:ELAN – Get Score) had its worth goal reduce by JPMorgan Chase & Co. from $24.00 to $20.00 in a analysis word issued to traders on Monday, The Fly stories. They presently have a impartial score on the inventory.

ELAN has been the subject of a number of different stories. Piper Sandler diminished their goal worth on Elanco Animal Well being from $22.00 to $21.00 and set a impartial score on the inventory in a report on Tuesday, August sixteenth. Barclays reduce their worth goal on Elanco Animal Well being from $32.00 to $18.00 and set an equal weight score on the inventory in a report on Monday, September twelfth. Morgan Stanley reduce their worth goal on Elanco Animal Well being from $22.00 to $21.00 and set an equal weight score on the inventory in a report on Friday, October seventh. Stifel Nicolaus reduce their worth goal on Elanco Animal Well being from $30.00 to $22.00 and set a maintain score on the inventory in a report on Friday, June twenty fourth. Lastly, The Goldman Sachs Group reduce Elanco Animal Well being from a purchase score to a promote score and reduce their worth goal for the inventory from $32.00 to $19.00 in a report on Thursday, July twenty first. One analyst has rated the inventory with a promote score and 5 have assigned a maintain score to the inventory. Based mostly on knowledge from MarketBeat.com, the inventory presently has a consensus score of Maintain and a mean worth goal of $20.17.

Elanco Animal Well being Inventory Up 4.9%

ELAN inventory opened at $12.33 on Monday. The corporate has a market cap of $5.85 billion, a PE ratio of -35.23, a price-to-earnings-growth ratio of 1.19 and a beta of 0.92. The enterprise has a 50-day easy shifting common of $14.90 and a 200 day easy shifting common of $19.91. Elanco Animal Well being has a 52 week low of $11.34 and a 52 week excessive of $35.00. The corporate has a fast ratio of 1.47, a present ratio of two.47 and a debt-to-equity ratio of 0.84.

Need Extra Nice Investing Concepts?

Elanco Animal Well being (NYSE:ELAN – Get Score) final posted its quarterly earnings outcomes on Monday, August eighth. The corporate reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.10. The enterprise had income of $1.18 billion in the course of the quarter, in comparison with the consensus estimate of $1.18 billion. Elanco Animal Well being had a constructive return on fairness of seven.40% and a destructive web margin of three.77%. Elanco Animal Well being’s income for the quarter was down 8.0% in comparison with the identical quarter final 12 months. Throughout the identical quarter within the earlier 12 months, the agency earned $0.28 earnings per share. Promote-side analysts anticipate that Elanco Animal Well being will submit 1.09 EPS for the present fiscal 12 months.

Insider Exercise at Elanco Animal Well being

In associated information, insider Rajeev A. Modi bought 6,700 shares of the inventory in a transaction that occurred on Friday, September ninth. The inventory was acquired at a mean value of $14.90 per share, with a complete worth of $99,830.00. Following the transaction, the insider now owns 41,157 shares of the corporate’s inventory, valued at roughly $613,239.30. The acquisition was disclosed in a submitting with the Securities & Alternate Fee, which will be accessed by the SEC web site. In associated information, Director R David Hoover bought 20,000 shares of the inventory in a transaction that occurred on Friday, September ninth. The inventory was acquired at a mean value of $15.18 per share, with a complete worth of $303,600.00. Following the transaction, the director now owns 145,000 shares of the corporate’s inventory, valued at roughly $2,201,100. The acquisition was disclosed in a submitting with the Securities & Alternate Fee, which will be accessed by the SEC web site. Additionally, insider Rajeev A. Modi purchased 6,700 shares of the agency’s inventory in a transaction dated Friday, September ninth. The shares had been acquired at a mean value of $14.90 per share, with a complete worth of $99,830.00. Following the completion of the transaction, the insider now owns 41,157 shares within the firm, valued at $613,239.30. The disclosure for this buy will be discovered right here. Within the final three months, insiders bought 56,700 shares of firm inventory valued at $839,630. 6.40% of the inventory is owned by insiders.

Institutional Traders Weigh In On Elanco Animal Well being

A number of giant traders have just lately made modifications to their positions within the enterprise. Dodge & Cox elevated its place in shares of Elanco Animal Well being by 72.1% in the course of the 2nd quarter. Dodge & Cox now owns 49,206,190 shares of the corporate’s inventory valued at $965,918,000 after buying a further 20,618,487 shares over the last quarter. Vanguard Group Inc. grew its stake in shares of Elanco Animal Well being by 1.6% in the course of the 1st quarter. Vanguard Group Inc. now owns 41,452,530 shares of the corporate’s inventory value $1,081,496,000 after buying a further 650,715 shares in the course of the interval. Primecap Administration Co. CA grew its stake in shares of Elanco Animal Well being by 2.1% in the course of the 1st quarter. Primecap Administration Co. CA now owns 30,784,292 shares of the corporate’s inventory value $803,162,000 after buying a further 625,326 shares in the course of the interval. Black Rock Inc. grew its stake in shares of Elanco Animal Well being by 6.6% in the course of the 1st quarter. Black Rock Inc. now owns 26,217,917 shares of the corporate’s inventory value $684,027,000 after buying a further 1,631,045 shares in the course of the interval. Lastly, Amundi grew its stake in shares of Elanco Animal Well being by 9.2% in the course of the 2nd quarter. Amundi now owns 15,571,115 shares of the corporate’s inventory value $305,349,000 after buying a further 1,313,013 shares in the course of the interval. 98.15% of the inventory is owned by hedge funds and different institutional traders.

Elanco Animal Well being Firm Profile

(Get Score)

Elanco Animal Well being Included, an animal well being firm, innovates, develops, manufactures, and markets merchandise for pets and cattle. It affords pet well being illness prevention merchandise, comparable to parasiticide and vaccine merchandise that shield pets from worms, fleas, and ticks underneath the Seresto, Benefit, Advantix, and Advocate manufacturers; pet well being therapeutics for ache, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines underneath the Galliprant and Claro manufacturers; vaccines, antibiotics, parasiticides, and different merchandise to be used in poultry and aquaculture manufacturing, in addition to dietary well being merchandise, together with enzymes, probiotics, and prebiotics; and a spread of vaccines, antibiotics, implants, parasiticides, and different merchandise utilized in ruminant and swine manufacturing underneath the Rumensin and Baytril manufacturers.

Additional Studying

The Fly logo

Analyst Recommendations for Elanco Animal Health (NYSE:ELAN)

Obtain Information & Scores for Elanco Animal Well being Day by day – Enter your electronic mail handle under to obtain a concise every day abstract of the most recent information and analysts’ rankings for Elanco Animal Well being and associated firms with MarketBeat.com’s FREE every day electronic mail e-newsletter.